A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours
A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours, Published online: 13 March 2018; doi:10.1038/s41416-018-0006-0
A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumourshttp://ift.tt/2FCAxGo
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου